Company Overview and News

How Gold and Silver Performed amid Geopolitical Tensions

23h marketrealist
The past one month has been good for precious metals with the exception of platinum. Gold, silver, and palladium have increased a whopping 3%, 6.4%, and 4.4%, respectively, during the last 30 trading days. Platinum has dropped about 0.97% during the same timeframe. All the four precious metals rose on Wednesday most likely due to the prevailing geopolitical tensions.
Upvote Downvote

A Millennial Boom In Asia And An Asymmetric Opportunity In Precious Metals

2018-04-20 valuewalk
As always, if you come across something cool during the week, shoot me an email at and I’ll share it with the group.
Upvote Downvote

Are Equity Markets’ Valuations Stretched?

2018-04-20 marketrealist
The International Monetary Fund (or IMF) also warned that the downside risks to world financial stability have increased over the past six months. It added that investors “should not take too much comfort” that the implications of the sharp sell-off in February 2018 didn’t lead to any major disruptions. In this context, it added, “Valuations of risky assets are still stretched, with some late-stage credit cycle dynamics emerging, reminiscent of the pre-crisis period.
Upvote Downvote

Miners’ Correlation with Gold in April

2018-04-19 marketrealist
In this part of our series, we’ll look at the correlation between gold and four mining stocks: Franco-Nevada (FNV), Coeur Mining (CDE), Kinross Gold (KGC), and Eldorado Gold (EGO). Mining stocks mostly move with gold prices, but not always. Among these four miners, Kinross has shown the highest correlation with gold this year, while Eldorado Gold has seen a negative correlation.
Upvote Downvote

Increased Volatility and Gold Investors

2018-04-17 marketrealist
While gold miners have been out of favor for a long time, that might be about to change. Since the uncertainty in the market is increasing, gold prices are poised to rise. This rise should be followed by gold miners (GDX), which are essentially a leveraged play on gold prices. Moreover, gold miners as a group have emerged as much stronger, leaner, and more competitive after their mistimed deals at the peak of the cycle, leading to debt escalations and substantial write-offs.
Upvote Downvote

Will Gold Take Cues from the Fed’s Decisions?

2018-04-17 marketrealist
Overall, gold has been rising in 2018, mainly due to the geopolitical tensions that keep increasing. First, we had fears of a US-China trade war, and now we have the Syrian chemical attack and subsequent air strikes. Another crucial element is the decline of the US dollar, which we’ll look at in the next part of this series.
Upvote Downvote

CDE / Coeur Mining, Inc. DEFA14A

Upvote Downvote

Is the Correlation of Mining Shares Mixed or Directional?

2018-04-11 marketrealist
In this part of our series, we’ll look at the correlation between gold and four mining stocks: Coeur Mining (CDE), Barrick Gold (ABX), Kinross Gold (KGC), and Eldorado Gold (EGO). Mining stocks mostly move with gold prices but not always. Among these four miners, Kinross Gold has shown the highest correlation with gold, while Eldorado Gold has seen a negative correlation to gold on a YTD (year-to-date) basis.
Upvote Downvote

How Miners Correlate to Gold in April 2018

2018-04-10 marketrealist
In this part of our series, we’ll look at the correlation between gold and four mining stocks: Franco-Nevada (FNV), Coeur Mining (CDE), Cia De Minas Buenaventura (BVN), and Hecla Mining (HL). Mining stocks mostly move with gold prices but not always. Among these four miners under discussion, Cia De Minas has shown the highest correlation with gold, while Hecla has the lowest correlation to gold on a YTD (or year-to-date) basis.
Upvote Downvote

How the Palladium Slump Affects the Gold-Palladium Spread

2018-04-09 marketrealist
Palladium has been the weakest performer among the four precious metals on a YTD (year-to-date) basis. It has fallen 16.1% YTD and was trading at $908.3 on April 5. Palladium is more inclined toward its industrial side than its use as a precious metal due to its many industrial uses.
Upvote Downvote

CDE / Coeur Mining, Inc. 8-K (Current Report)

Upvote Downvote

2 Mines Supply Half Of U.S. Silver Production And The Real Cost To Produce Silver

2018-04-09 seekingalpha
Just two mines supply the United States with half of its silver production, and both are located in Alaska. It's quite amazing that Alaska now produces half of the silver for the U.S. when only 30 years ago total mine supply from the state was less than 50,000 oz per year. The silver produced in Alaska comes from the Greens Creek and Red Dog Mines. One is a primary silver mine and the other a zinc-lead base metal mine.
Upvote Downvote

How Economic Data Could Play Precious Metals

Over the last week, we saw some crucial economic numbers for the United States, including quarterly GDP, a measurement of the annualized change in the inflation-adjusted value of all goods and services over the last quarter. The market was expecting this number to be 2.7%. However, the outcome beat expectations at 2.9%. A better-than-expected number could be detrimental for gold since the demand for this safe-haven asset decreases.
Upvote Downvote

Gold Mining Bull: Top News And Month In Review

2018-04-04 seekingalpha
Here's a monthly recap of the top news in the gold mining sector, including drill results, takeover announcements and other relevant updates, to keep readers up-to-date on news in the sector. Here's my update for February if you missed it.
Upvote Downvote

Equity Market Correction: The Next Catalyst for Gold Prices?

The US equity market has been on an upward trend since the US presidential election in November 2016. The S&P 500 Index (SPY)(SPX) rose nearly 30.0% between November 2016 and March 2018. The expectation of various reforms, deregulation under the new administration, and an improvement in various fundamental factors primarily supported the market movement.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 192108504